Multiple Choice
Dopamine is a neurotransmitter involved in the reward pathways in the brain, and its decreased activity has been associated with diseases such as Parkinson's disease and attention-deficit/hyperactivity disorder (ADHD) . Which of the following drugs is NOT a likely candidate to treat these diseases?
A) Methylphenidate, a dopamine reuptake inhibitor
B) Amphetamine, a dopamine-releasing agent that triggers the release of dopamine into the synaptic cleft
C) Carbidopa, which enhances the availability of the dopamine synthesis precursors in the brain
D) Forskolin, a sensitizer of dopamine receptors
E) Chlorpromazine, a dopamine antagonist that binds to and inhibits dopamine receptors
Correct Answer:

Verified
Correct Answer:
Verified
Q17: Which of the following graphs better represents
Q18: Which of the following is the reason
Q19: Astroglial cells in the brain can actively
Q20: Each single neuron acts as a computational
Q21: Most eukaryotic ABC transporters are involved in
Q23: A certain neuron in a mouse brain
Q24: Aquaporin has a pair of key asparagine
Q25: The inactivation rate of voltage-gated Na⁺ and
Q26: After release into the synaptic cleft, the
Q27: Indicate true (T) and false (F) statements